Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Ophthalmology

Fuchs vs. Other Corneal Dystrophies: Key Differences

At a Glance

Fuchs' dystrophy affects the inner cornea, causing fluid buildup and swelling that usually begins in your 50s. Lattice, Granular, and Macular dystrophies affect the middle cornea, causing physical deposits and painful eye scratches that typically start in childhood or adolescence.

Corneal dystrophies are a group of rare, genetic eye disorders where abnormal material builds up in the clear front surface of the eye (the cornea), gradually affecting vision. If you have been diagnosed with one, you may wonder how your condition compares to others. The primary difference lies in how they affect the eye: Fuchs’ endothelial corneal dystrophy affects the innermost layer of the cornea (the endothelium), causing fluid to build up and leading to swelling (edema) and blurred vision [1][2]. In contrast, Lattice, Granular, and Macular dystrophies are stromal dystrophies that affect the middle, thickest layer of the cornea (the stroma) [3]. Instead of fluid buildup, these stromal dystrophies cause abnormal proteins or carbohydrates to accumulate, which can lead to painful scratches on the eye surface (corneal erosions) and progressive cloudiness [4][5][6]. They also tend to appear much earlier in life than Fuchs’ dystrophy [7][8].

The Core Difference: Fluid Buildup vs. Physical Deposits

Fuchs’ dystrophy is an endothelial disease [1]. The endothelium is the innermost layer of the cornea, acting as a pump to clear fluid. In Fuchs’, these pump cells slowly die off, causing fluid to accumulate (corneal edema) [2]. Patients typically experience blurry vision that is worse in the morning but clears up as the day goes on [2].

Lattice, Granular, and Macular dystrophies are stromal diseases [1][3]. The stroma is the middle layer of the cornea. Rather than fluid buildup, these conditions involve the accumulation of specific types of physical deposits within the stroma [4][5].

Comparing the Three Stromal Dystrophies

While Fuchs’ primarily causes swelling, the stromal dystrophies share a tendency to cause recurrent corneal erosions [6]. These are painful episodes where the outermost layer of the cornea tears off, often happening suddenly when waking up or first opening the eyes in the morning [9]. Fortunately, there are treatments like lubricating ointments or special bandage contact lenses that can help prevent and manage these painful mornings.

However, the three stromal dystrophies differ in the type of deposits they cause:

  • Lattice Corneal Dystrophy: Causes branching, web-like lines of amyloid (a type of abnormal protein) to form in the stroma [1]. These deposits can lead to significant pain and vision loss due to frequent erosions [10][11].
  • Granular Corneal Dystrophy: Characterized by discrete, crumb-like white deposits of a protein substance called hyaline [4][12]. Over time, these spots can increase in number and merge, causing vision to become cloudy [12].
  • Macular Corneal Dystrophy: Caused by the buildup of abnormal carbohydrates (glycosaminoglycans) [5]. Unlike the defined spots of Granular dystrophy, Macular dystrophy causes a diffuse, widespread haze across the entire cornea [13]. While primarily a stromal disease, this haze is unique because it can eventually progress to involve the innermost layers of the cornea (the endothelium) as well [13].

Age of Onset and Progression

Another major difference is when symptoms usually begin:

  • Fuchs’ Dystrophy: Typically a later-onset condition. While microscopic changes may begin earlier, patients usually do not notice symptoms until their 50s or 60s [7].
  • Stromal Dystrophies: Lattice, Granular, and Macular dystrophies generally appear much earlier in life, often in childhood (the first or second decade of life) or early adolescence [8][14][15]. Macular dystrophy, in particular, tends to cause a more rapid and progressive decline in vision [15].

Differences in Medical and Surgical Treatment

Because they affect different parts of the cornea in different ways, their management varies:

  • Fuchs’ Dystrophy Treatment: Early stages are managed with special hypertonic saline eye drops (like Muro 128) or ointments to draw fluid out of the swollen cornea. If vision declines significantly, doctors perform targeted partial-thickness cornea transplants (like DMEK or DSAEK) that replace only the damaged inner pump cells [16][17].
  • Stromal Dystrophy Treatment: Early stages focus on preventing and treating painful corneal erosions using lubricating drops, ointments, or bandage contact lenses. As the protein or carbohydrate deposits worsen and cloud vision, a laser procedure called PTK (phototherapeutic keratectomy) can be used to remove the deposits [11]. If the deposits are too deep, a different type of transplant that replaces the middle stroma (like DALK) or a full-thickness transplant may be necessary [15][18].

Genetics and Inheritance

Fuchs’ dystrophy is often a complex genetic disorder, sometimes linked to specific genetic repeats (TCF4 gene) [19]. Lattice and Granular dystrophies are usually passed down through families in an autosomal dominant pattern, meaning you only need one copy of the mutated gene to develop the disease (usually the TGFBI gene) [20][21]. Macular dystrophy is autosomal recessive, meaning both parents must pass on a copy of the mutated CHST6 gene for the child to have the disease [5].

Practical Tip for Families: Because these conditions are genetic, an open conversation with your family is helpful. If you have an autosomal dominant type (Lattice or Granular), your siblings and children have a 50% chance of inheriting it, and they may want to be screened by an eye doctor.

SAFETY ALERT: Avoid LASIK
If you have a stromal dystrophy, especially Granular or Lattice, keratorefractive procedures like LASIK can trigger rapid disease progression and significantly worsen your vision [4][22]. Always ensure any eye surgeon is aware of your specific dystrophy diagnosis.

Summary Comparison Table

Feature Fuchs’ Dystrophy Lattice Dystrophy Granular Dystrophy Macular Dystrophy
Primary Layer Affected Endothelium (Innermost) Stroma (Middle) Stroma (Middle) Stroma (can spread deeper)
Main Issue Fluid buildup (swelling) Amyloid deposits Hyaline deposits Carbohydrate deposits
Typical Onset Age 50s and 60s Childhood / Early Teens Childhood / Early Teens First decade (Childhood)
Inheritance Pattern Complex / Variable Autosomal Dominant Autosomal Dominant Autosomal Recessive

Common questions in this guide

What is the main difference between Fuchs and other corneal dystrophies?
Fuchs' dystrophy affects the inner layer of the cornea and causes fluid buildup or swelling. In contrast, Lattice, Granular, and Macular dystrophies affect the middle layer and cause physical deposits of proteins or carbohydrates to form.
Why do I wake up with eye pain if I have a stromal corneal dystrophy?
Stromal dystrophies can cause painful episodes called recurrent corneal erosions, where the outermost layer of the eye tears off. This often happens suddenly when opening your eyes in the morning. Lubricating ointments or bandage contact lenses can help prevent this pain.
At what age do corneal dystrophy symptoms usually start?
Lattice, Granular, and Macular dystrophies typically appear early in life, often during childhood or early adolescence. Fuchs' dystrophy usually develops later, with patients generally not noticing blurry vision until their 50s or 60s.
Can I get LASIK if I have a corneal dystrophy?
You should generally avoid LASIK if you have a stromal dystrophy, especially the Granular or Lattice types. These procedures can trigger rapid disease progression and significantly worsen your vision. Always inform your eye surgeon about your specific diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific subtype of corneal dystrophy do I have, and how does that affect my long-term treatment plan?
  2. 2.Given my specific type of dystrophy, am I at higher risk for corneal swelling (edema) or painful corneal erosions?
  3. 3.What steps can I take or treatments can I use right now to prevent painful morning eye tears?
  4. 4.How quickly does this specific type of dystrophy typically progress compared to others?
  5. 5.Are there any specific activities or eye procedures, like LASIK or PRK, that I should absolutely avoid?
  6. 6.Should my children or siblings be evaluated or genetically tested for this condition, and if so, at what age?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Imaging pathology in archived cornea with Fuchs' endothelial corneal dystrophy including tissue reprocessing for volume electron microscopy.

    Maeno S, Lewis PN, Young RD, et al.

    Scientific reports 2024; (14(1)):31786 doi:10.1038/s41598-024-82888-5.

    PMID: 39738318
  2. 2

    Differences in Guttae Ultramorphology in Relation to Visual Function in Fuchs Endothelial Corneal Dystrophy.

    Weller JM, Bennemann M, Tourtas T, et al.

    Cornea 2024; (43(11)):1348-1354 doi:10.1097/ICO.0000000000003504.

    PMID: 38391241
  3. 3

    IC3D Classification of Corneal Dystrophies-Edition 3.

    Weiss JS, Rapuano CJ, Seitz B, et al.

    Cornea 2024; (43(4)):466-527 doi:10.1097/ICO.0000000000003420.

    PMID: 38359414
  4. 4

    Deterioration of Avellino corneal dystrophy in a Chinese family after LASIK.

    Jiang X, Zhang H

    International journal of ophthalmology 2021; (14(6)):795-799 doi:10.18240/ijo.2021.06.02.

    PMID: 34150532
  5. 5

    Macular Corneal Dystrophy: An Updated Review.

    Singh S, Das S, Kannabiran C, et al.

    Current eye research 2021; (46(6)):765-770 doi:10.1080/02713683.2020.1849727.

    PMID: 33171054
  6. 6

    Diurnal Variation in Straylight in Patients With Fuchs Endothelial Corneal Dystrophy and Controls.

    de Jong B, Brandi-Dohrn F, van der Meulen IJE, et al.

    Cornea 2023; (42(2)):164-171 doi:10.1097/ICO.0000000000003002.

    PMID: 35120348
  7. 7

    Demographic profile and clinical characteristics of Fuchs' endothelial corneal dystrophy in a tertiary eye care center.

    Bhadra P, Sahoo S, Sahu SK, et al.

    Indian journal of ophthalmology 2023; (71(2)):505-509 doi:10.4103/ijo.IJO_1288_22.

    PMID: 36727349
  8. 8

    A Novel Heterozygous TGFBI c.1613C>A Pathogenic Variant is Associated With Lattice Corneal Dystrophy in a Chinese Family.

    Fu M, Duan S, Zhang X, et al.

    American journal of ophthalmology 2023; (256()):138-145 doi:10.1016/j.ajo.2023.08.005.

    PMID: 37567434
  9. 9

    Corneal histomorphology and electron microscopic observation of R124L mutated corneal dystrophy in a relapsed pedigree.

    Fu MJ, Zhao J, Duan S, et al.

    International journal of ophthalmology 2022; (15(9)):1416-1422 doi:10.18240/ijo.2022.09.02.

    PMID: 36124191
  10. 10

    Diurnal Variation in Corneal Edema in Fuchs Endothelial Corneal Dystrophy.

    Fritz M, Grewing V, Maier P, et al.

    American journal of ophthalmology 2019; (207()):351-355 doi:10.1016/j.ajo.2019.08.002.

    PMID: 31415734
  11. 11

    Recurrence and Visual Outcomes of Phototherapeutic Keratectomy in Lattice Corneal Dystrophy: A Cohort Study.

    Sauvageot P, Julio G, Bolaños JV, et al.

    Journal of refractive surgery (Thorofare, N.J. : 1995) 2022; (38(1)):43-49 doi:10.3928/1081597X-20211104-01.

    PMID: 35020539
  12. 12

    In Vivo Confocal Microscopy Findings in Corneal Stromal Dystrophies.

    Okudan S, Tınkır Kayıtmazbatır E, Bozkurt Oflaz A, Bozkurt B

    Diagnostics (Basel, Switzerland) 2025; (15(2)) doi:10.3390/diagnostics15020182.

    PMID: 39857066
  13. 13

    Macular Corneal Dystrophy in an Adolescent Managed with Deep Anterior Lamellar Keratoplasty.

    Giri P, Bajracharya L, Ranabhat S

    Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2022; (14(27)):204-209 doi:10.3126/nepjoph.v14i1.39633.

    PMID: 35996921
  14. 14

    A case of paternity-confirmed de novo R124H mutation resulting in granular corneal dystrophy type 2.

    Min JS, Kim TI, Shin KJ, et al.

    Ophthalmic genetics 2025; (46(5)):513-515 doi:10.1080/13816810.2025.2507085.

    PMID: 40556321
  15. 15

    Bilateral phototherapeutic keratectomy for corneal macular dystrophy in an adolescent: case report and review of the literature.

    Shields M, Craig JE, Souzeau E, Gupta A

    Ophthalmic genetics 2020; (41(4)):368-372 doi:10.1080/13816810.2020.1776335.

    PMID: 32543930
  16. 16

    Descemet Stripping Without Endothelial Keratoplasty in Early-Stage Central Fuchs Endothelial Dystrophy: Long-term Results.

    Vieira R, Castro C, Coelho J, et al.

    Cornea 2023; (42(8)):980-985 doi:10.1097/ICO.0000000000003131.

    PMID: 36731082
  17. 17

    Descemet Stripping Only for Symptomatic Fuchs Endothelial Dystrophy-A Retrospective Case Series Comparing ROCK-I vs. Hypertonic Sodium Chloride for Post-Surgical Adjuvant Therapy.

    Cohen E, Din N, Aldrees S, et al.

    Journal of clinical medicine 2025; (14(5)) doi:10.3390/jcm14051512.

    PMID: 40095027
  18. 18

    Descemet Stripping Only for a Chronic Descemet Detachment After Cataract Surgery.

    Hirabayashi KE, Mark D, Lau J, Lin CC

    Cornea 2020; (39(3)):379-381 doi:10.1097/ICO.0000000000002195.

    PMID: 31725698
  19. 19

    A multi-ancestry GWAS of Fuchs corneal dystrophy highlights the contributions of laminins, collagen, and endothelial cell regulation.

    Gorman BR, Francis M, Nealon CL, et al.

    Communications biology 2024; (7(1)):418 doi:10.1038/s42003-024-06046-3.

    PMID: 38582945
  20. 20

    Association of rs613872 and Trinucleotide Repeat Expansion in the TCF4 Gene of German Patients With Fuchs Endothelial Corneal Dystrophy.

    Okumura N, Hayashi R, Nakano M, et al.

    Cornea 2019; (38(7)):799-805 doi:10.1097/ICO.0000000000001952.

    PMID: 30973406
  21. 21

    Analysis of TGFBI Gene Mutations in Three Chinese Families with Corneal Dystrophy.

    Zhao F, Liu Y, Guan T

    Journal of ophthalmology 2019; (2019()):6769013 doi:10.1155/2019/6769013.

    PMID: 30805211
  22. 22

    Case Report: Post-LASIK exacerbation of granular corneal dystrophy type 2: a familial case with TGFBI mutation.

    Kuang L, Zhang X, Wang Y, et al.

    Frontiers in medicine 2025; (12()):1721130 doi:10.3389/fmed.2025.1721130.

    PMID: 41446838

This page explains the differences between types of corneal dystrophy for educational purposes. Your ophthalmologist is the best source for diagnosing and managing your specific eye condition.

Get notified when new evidence is published on Corneal dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.